Dr. Guido Marchi
Physician-researcher in Onco-Pulmonology
Azienda Ospedaliero-Universitaria Pisana — Pulmonary Unit
Immune-related toxicities IMPEREALImmune Checkpoint Inhibitor–Related Pneumonitis: Real-World Incidence Analysis in Lung Cancer Patients
A real-world analysis of the incidence of checkpoint inhibitor–induced pneumonitis (CIP) in lung cancer patients treated with immunotherapy. A 10-year retrospective cohort at AOU P...